Q2 2023 13F Holders as of 30 Jun 2023
-
Type / Class
-
Equity / Common stock, par value $0.0001 per share
-
Shares outstanding
-
151,865,218
-
Total 13F shares
-
135,867,468
-
Share change
-
+2,700,010
-
Total reported value
-
$911,627,693
-
Put/Call ratio
-
55%
-
Price per share
-
$6.71
-
Number of holders
-
204
-
Value change
-
+$14,825,464
-
Number of buys
-
82
-
Number of sells
-
104
Institutional Holders of Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) as of Q2 2023
As of 30 Jun 2023,
Adaptive Biotechnologies Corp - Common stock, par value $0.0001 per share (ADPT) was held by
204 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
135,867,468 shares.
The largest 10 holders included
VIKING GLOBAL INVESTORS LP, VANGUARD GROUP INC, Matrix Capital Management Company, LP, BlackRock Inc., ARK Investment Management LLC, Sumitomo Mitsui Trust Holdings, Inc., Nikko Asset Management Americas, Inc., Aristotle Atlantic Partners, LLC, Blue Water Life Science Advisors, LP, and PICTET ASSET MANAGEMENT SA.
This page lists
206
institutional shareholders reporting positions in this security
for the Q2 2023 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.